Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 07, 2026
TickeronGET DAILY SIGNALS
HIVE Digital Technologies (HIVE) Drops -35% as Bitcoin Pullback Hits Crypto Miners and AI Infrastructure Peers

HIVE Digital Technologies (HIVE) Drops -35% as Bitcoin Pullback Hits Crypto Miners and AI Infrastructure Peers

Key Takeaways

  • HIVE Digital Technologies (HIVE) fell roughly 35% over the last 30 days, sliding from about $2.75 to near $1.78.
  • The decline tracked a pullback in Bitcoin prices and broad weakness across crypto-mining and AI-infrastructure peers.
  • Analysts trimmed price targets, while a large fiscal first-quarter GAAP net loss weighed on sentiment.
  • The stock broke below its 50-day and 200-day moving averages, reinforcing a near-term technical downtrend.
  • The company's longer-term AI and high-performance computing pivot through its BUZZ HPC subsidiary remains a key growth narrative.
  • For additional detail on valuation, results, and projections, explore the Price Targets, Earnings, and Forecast pages.

HIVE Digital Technologies Company Overview and Market Position

HIVE Digital Technologies Ltd. builds and operates data centers powered primarily by renewable energy across Canada, Sweden, and Paraguay. The company began as one of the first publicly listed Bitcoin miners to emphasize green energy, and it continues to generate revenue from digital currency mining. In recent years, HIVE has accelerated a strategic pivot toward high-performance computing (HPC) and AI cloud services through its BUZZ HPC subsidiary, which rents out graphics processing units to enterprise customers. Investors follow the stock both for its exposure to Bitcoin and for its efforts to build a steadier, contract-based revenue stream in the AI infrastructure market. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

HIVE Digital Technologies Stock Price Performance: Last 30 Days vs. Quarter

Over the last 30 days, HIVE shares declined approximately 35%, falling from a closing level near $2.75 in early October to roughly $1.78 in early November. The move was not isolated; it occurred alongside a retreat in Bitcoin prices and a broad risk-off tilt across the sector.

The quarterly picture is similar. Measured from early August, when shares traded near $2.76, the stock is down about 35% as well. HIVE rallied into mid-September, reaching levels around $3.40 after announcing its largest AI contract to date, before giving back those gains as crypto prices pulled back and investor sentiment toward the group weakened.

What Drove HIVE Stock Price in the Last 30 Days

Several factors combined to pressure HIVE over the past month. First, Bitcoin retreated from its record highs, dragging down the valuation of miners whose revenue is tied to digital asset prices. Weaker Bitcoin and softer mining economics reduced the appeal of the mining side of the business.

Second, sentiment toward crypto-mining and AI-infrastructure names deteriorated more broadly. Treasury yields near multi-decade highs and a risk-off environment weighed on capital-intensive growth stories across the sector.

Third, sell-side analysts trimmed price targets on HIVE, with firms such as Keefe, Bruyette & Woods lowering their outlooks. Combined with a large fiscal first-quarter GAAP net loss — driven in part by a non-cash VAT-related charge tied to its Swedish operations — the revisions added to selling pressure.

Finally, from a technical standpoint, the stock broke below its 50-day and 200-day moving averages, which often triggers further momentum-based selling.

What Drove HIVE Stock Performance Over the Last Quarter

Over the broader quarter, HIVE's story has been defined by its continued transition toward AI and HPC. The company signed a five-year, roughly $350 million GPU cloud agreement in August, its largest AI contract to date, and announced that BUZZ HPC had accumulated more than $600 million in GPU cloud contracts. Those announcements helped push shares higher into mid-September.

However, the rally faded as the crypto market cooled and as investors reassessed execution risk, financing needs, and profitability. The fiscal first-quarter report showed strong revenue growth but a substantial GAAP loss, while heavy capital requirements for the AI buildout remained in focus. The net result was a quarter that began and ended near similar levels, with most of the decline concentrated in the final month.

HIVE Stock Forecast Drivers: What Investors Should Watch Next

Looking ahead, the direction of Bitcoin prices remains the most immediate swing factor for HIVE's mining revenue and overall sentiment. Investors should also monitor the company's quarterly earnings and updates on the deployment of its NVIDIA GPU clusters, progress toward its GPU cloud revenue targets, and any changes in analyst price targets or financing activity. Broader macroeconomic conditions, including interest rates and risk appetite, will continue to influence how the market values capital-intensive crypto and AI-infrastructure businesses. From what I see, this is important because execution on the AI side could provide a buffer if Bitcoin volatility persists.

Using AI Tools for Market Context

One tool I find useful for this kind of analysis is Tickeron’s AI Trading Bots. It lets me review how automated strategies are positioning across the market and offers a useful starting point for data-driven signals on names like HIVE.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: HIVE

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


HIVE's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for HIVE turned positive on November 06, 2026. Looking at past instances where HIVE's MACD turned positive, the stock continued to rise in 33 of 37 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where HIVE's RSI Oscillator exited the oversold zone, 36 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +6.43% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIVE advanced for three days, in 211 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

HIVE may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 01, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HIVE as a result. In 67 of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

HIVE moved below its 50-day moving average on October 05, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HIVE crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

The 50-day moving average for HIVE moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIVE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for HIVE entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 14 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 68 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.972) is normal, around the industry mean (3.132). P/E Ratio (9.174) is within average values for comparable stocks, (6.756). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (0.809). Dividend Yield (0.000) settles around the average of (8.982) among similar stocks. P/S Ratio (2.169) is also within normal values, averaging (16.899).

The Tickeron Price Growth Rating for this company is 90 (best 1 - 100 worst), indicating slightly worse than average price growth. HIVE’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIVE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.

Notable companies

The most notable companies in this group are Morgan Stanley (NYSE:MS), Goldman Sachs Group (NYSE:GS), Charles Schwab Corp (The) (NYSE:SCHW), Gold.com Inc. (NYSE:GOLD).

Industry description

These banks specialize in underwriting (helping companies with debt financing or equity issuances), IPOs, facilitating mergers and other corporate reorganizations and acting as a broker or financial advisor for institutions. They might also trade securities on their own accounts. Investment banks potentially thrive on expanding its network of clients, since that could help them increase profits. Goldman Sachs, Morgan Stanley and CME Group Inc are some of the largest investment banking companies.

Market Cap

The average market capitalization across the Investment Banks/Brokers Industry is 11.55B. The market cap for tickers in the group ranges from 590 to 284.96B. MS holds the highest valuation in this group at 284.96B. The lowest valued company is FSSLD at 590.

High and low price notable news

The average weekly price growth across all stocks in the Investment Banks/Brokers Industry was -5%. For the same Industry, the average monthly price growth was -22%, and the average quarterly price growth was -28%. PMAX experienced the highest price growth at 90%, while ABTS experienced the biggest fall at -68%.

Volume

The average weekly volume growth across all stocks in the Investment Banks/Brokers Industry was -16%. For the same stocks of the Industry, the average monthly volume growth was 28% and the average quarterly volume growth was -39%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 67
P/E Growth Rating: 66
Price Growth Rating: 71
SMR Rating: 74
Profit Risk Rating: 87
Seasonality Score: -8 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of cloud networking and enterprise Wi-Fi solution

Industry InvestmentBanksBrokers

Industry
Computer Communications
Address
7900 Callaghan Road
Phone
+1 604 664-1078
Employees
29
Web
https://www.hivedigitaltechnologies.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of $1.54 billion, reflecting approximately 74% year-over-year growth. Consensus earnings per share (EPS) forecast stands at $0.28, up over 115% from the prior year.
Analysts expect Q1 2026 revenue of $3.00 billion, up 8% from $2.77 billion in the year-ago quarter. Consensus earnings per share (EPS) estimate stands at $4.31, reflecting steady profitability from the cystic fibrosis (CF) portfolio.